Repligen
Generated by Meeveem AI
"Bioprocessing technology leader advancing the production of biologic drugs worldwide"
About Repligen
Repligen develops and manufactures bioprocessing tools and technologies that enable the production of biologic drugs, from monoclonal antibodies to gene therapies, viral vectors, and mRNA. Founded in 1981, the company pioneered filtration systems, chromatography solutions, process analytics, and upstream intensification technologies that help biopharmaceutical manufacturers improve yield, reduce costs, and accelerate development. The company serves customers worldwide with solutions spanning the entire bioprocessing workflow. By combining technical expertise with a customer first approach, Repligen enables manufacturers to overcome production challenges, scale new modalities, and deliver life saving medicines to patients faster.
2000
Team Members
1981
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where bioprocessing innovation accelerates the delivery of life saving biologic therapies to every patient who needs them
Our Mission
At Repligen, our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide